Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Shares Repurchased: 2014-2022

Historic Shares Repurchased for Viking Therapeutics (VKTX) over the last 1 years, with Jun 2022 value amounting to $1.7 million.

  • Viking Therapeutics' Shares Repurchased was N/A to $1.7 million in Q2 2022 from the same period last year, while for Jun 2022 it was $6.8 million, marking a year-over-year change of. This contributed to the annual value of $6.8 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Viking Therapeutics reported Shares Repurchased of $1.7 million as of Q2 2022, which was down 67.31% from $5.1 million recorded in Q1 2022.
  • Viking Therapeutics' 5-year Shares Repurchased high stood at $5.1 million for Q1 2022, and its period low was $1.7 million during Q2 2022.
  • Its 1-year average for Shares Repurchased is $3.4 million, with a median of $3.4 million in 2022.